ARCT
Price
$12.79
Change
+$0.88 (+7.39%)
Updated
Jun 6 closing price
Capitalization
323.41M
64 days until earnings call
CVAC
Price
$4.41
Change
-$0.05 (-1.12%)
Updated
Jun 6 closing price
Capitalization
1.01B
67 days until earnings call
Interact to see
Advertisement

ARCT vs CVAC

Header iconARCT vs CVAC Comparison
Open Charts ARCT vs CVACBanner chart's image
Arcturus Therapeutics Holdings
Price$12.79
Change+$0.88 (+7.39%)
Volume$550.72K
Capitalization323.41M
CureVac
Price$4.41
Change-$0.05 (-1.12%)
Volume$302.31K
Capitalization1.01B
ARCT vs CVAC Comparison Chart
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. CVAC commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a StrongBuy and CVAC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ARCT: $11.82 vs. CVAC: $4.44)
Brand notoriety: ARCT and CVAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 77% vs. CVAC: 125%
Market capitalization -- ARCT: $323.41M vs. CVAC: $1.01B
ARCT [@Biotechnology] is valued at $323.41M. CVAC’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileCVAC’s FA Score has 0 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • CVAC’s FA Score: 0 green, 5 red.
According to our system of comparison, CVAC is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 6 TA indicator(s) are bullish while CVAC’s TA Score has 5 bullish TA indicator(s).

  • ARCT’s TA Score: 6 bullish, 2 bearish.
  • CVAC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than CVAC.

Price Growth

ARCT (@Biotechnology) experienced а -2.72% price change this week, while CVAC (@Biotechnology) price change was +13.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 11, 2025.

CVAC is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVAC($1.01B) has a higher market cap than ARCT($323M). CVAC YTD gains are higher at: 30.205 vs. ARCT (-30.348). CVAC has higher annual earnings (EBITDA): 166M vs. ARCT (-77.4M). CVAC has more cash in the bank: 555M vs. ARCT (237M). ARCT has less debt than CVAC: ARCT (28.6M) vs CVAC (40.1M). CVAC has higher revenues than ARCT: CVAC (543M) vs ARCT (138M).
ARCTCVACARCT / CVAC
Capitalization323M1.01B32%
EBITDA-77.4M166M-47%
Gain YTD-30.34830.205-100%
P/E RatioN/A4.90-
Revenue138M543M25%
Total Cash237M555M43%
Total Debt28.6M40.1M71%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTCVAC
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
87%
Momentum
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
81%
MACD
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
71%
Advances
ODDS (%)
Bullish Trend 19 days ago
80%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 25 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
82%
Aroon
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 11 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with BMEA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
-1.75%
BMEA - ARCT
51%
Loosely correlated
-2.11%
TRDA - ARCT
50%
Loosely correlated
+0.91%
ABCL - ARCT
50%
Loosely correlated
+3.03%
BNTX - ARCT
46%
Loosely correlated
-1.04%
RCKT - ARCT
46%
Loosely correlated
+6.44%
More

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
+2.07%
BNTX - CVAC
48%
Loosely correlated
-1.04%
MRNA - CVAC
48%
Loosely correlated
-2.65%
ARCT - CVAC
42%
Loosely correlated
-1.75%
NVAX - CVAC
41%
Loosely correlated
-6.23%
VXRT - CVAC
40%
Loosely correlated
-2.36%
More